Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance practices, such as confirmatory biopsy.
The cost of using ultrasounds tech costs around 10% of MRI scanning, which means doctors can now better guide prostate biopsies and focal therapy – which destroys cancer cells, the research team ...